GeneDx Holdings (WGS) Inventory (2020 - 2026)

GeneDx Holdings (WGS) has reported Inventory for 7 consecutive years, with $17.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory rose 49.35% year-over-year to $17.8 million in Q2 2026; TTM through Jun 2026 was $17.8 million, a 49.35% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, up 31.0% from the prior year.
• Inventory was $17.8 million for Q2 2026 at GeneDx Holdings, up from $12.2 million in the prior quarter.
• Over five years, Inventory peaked at $44.2 million in Q3 2022 and troughed at $8.8 million in Q4 2023.
• A 5-year average of $16.7 million and a median of $12.1 million in 2025 frame the typical range for Inventory.
• Across the five-year window, Inventory plunged 78.84% in 2023 and jumped 49.35% in 2026, its largest moves.
• Over 5 years, Inventory stood at $13.7 million in 2022, then slumped by 35.77% to $8.8 million in 2023, then climbed by 21.34% to $10.6 million in 2024, then soared by 31.0% to $14.0 million in 2025, then climbed by 27.73% to $17.8 million in 2026.
• The last three Inventory figures came in at $17.8 million (Q2 2026), $12.2 million (Q1 2026), and $14.0 million (Q4 2025), per Business Quant data.